A decisive quarter: cash conversion, lower net debt and M&A-driven mix shift#
Veralto’s most consequential development is financial and strategic at once: FY2024 revenue of $5.19 billion paired with free cash flow of $820 million that converts to net income at roughly +98.46%, while management has driven net debt down to $1.67 billion versus $2.02 billion a year earlier (a -17.33% change). Those balance-sheet and cash-generation moves — reported alongside a Q2 2025 operational beat (Q2 revenue $1.371 billion, adjusted EPS $0.93) and a step-up in the dividend — create the practical runway for the company’s buy-and-build strategy: buy recurring digital revenue (TraceGains), invest selectively in water-tech optionality (Emerald Global Water Fund II), and use robust cash flow to fund both. The result is a tension-filled picture: durable cash generation and lower leverage versus near-term PQI margin pressure linked to integration and tariffs.
Professional Market Analysis Platform
Make informed decisions with institutional-grade data. Track what Congress, whales, and top investors are buying.
Financial performance: steady top line, high-quality cash flow#
Veralto’s FY2024 core numbers show stability rather than breakout growth. Revenue rose to $5.19B from $5.02B in FY2023, a calculated year-on-year increase of +3.39% (5.19 / 5.02 - 1). Gross profit improved to $3.10B, producing a gross margin of 59.79% (3.10 / 5.19), while operating income reached $1.21B, an operating margin of 23.31% (1.21 / 5.19). Net income for the year was $833 million, a net margin of 16.04%. These outcomes indicate scale and robust unit economics in the company’s core businesses even as top-line growth remains mid-single digits.
More company-news-VLTO Posts
Veralto (VLTO) — Q2 Beat and Faster Software Mix Shift Balance Strong Cash Flow and Rising Leverage
Veralto reported an EPS beat in Q2 (adjusted EPS $0.93) and raised guidance; FY2024 shows robust margins, high FCF conversion (~98%), and a heavier net-debt profile to watch.
Veralto Corporation Q2 Beat: Revenue Growth, Guidance Raise & Capital Allocation
Veralto (VLTO) posted a Q2 beat—$1.371B revenue and $0.93 adj. EPS—raised FY guidance and committed €20M to Emerald Fund II, while Aquafides strengthens EU UV capacity.
Veralto Corporation Q2 2025 Earnings Beat & €20M Emerald Water Fund II Investment
Veralto surpasses Q2 2025 earnings estimates with strong operational execution and invests €20M in Emerald Water Fund II, reinforcing its leadership in water tech innovation.
Where Veralto materially distinguishes itself is cash conversion. FY2024 free cash flow was $820 million, which divided by reported net income of $833 million yields a free cash flow conversion rate of +98.46% (820 / 833). That level of conversion implies reported earnings are supported by equally strong operating cash generation and gives management optionality to reduce leverage, reinvest, or return capital to shareholders. Supporting this, net debt fell from $2.02B (2023) to $1.67B (2024) — a -17.33% reduction — driven by higher cash at period end and disciplined financing activity Veralto Q2 2025 Earnings Release.
Despite generally healthy margins, some TTM (trailing twelve months) metrics reported elsewhere in the dataset diverge from fiscal-year calculations. For example, published TTM debt-to-equity metrics differ from a simple fiscal-year-end calculation using total debt ($2.77B) and total stockholders' equity ($2.04B) which gives a FY2024 debt/equity of 1.36x (2.77 / 2.04). These differences most likely reflect alternate period definitions or adjustments (e.g., average equity, different debt definitions) and are discussed below where they affect leverage interpretation.
Income-statement snapshot (FY2021–FY2024)#
| Year | Revenue | Gross Profit | Operating Income | Net Income | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|---|---|---|---|
| 2024 | $5,190,000,000 | $3,100,000,000 | $1,210,000,000 | $833,000,000 | 59.79% | 23.31% | 16.04% |
| 2023 | $5,020,000,000 | $2,900,000,000 | $1,140,000,000 | $839,000,000 | 57.78% | 22.70% | 16.71% |
| 2022 | $4,870,000,000 | $2,770,000,000 | $1,110,000,000 | $845,000,000 | 56.75% | 22.79% | 17.35% |
| 2021 | $4,700,000,000 | $2,710,000,000 | $1,040,000,000 | $861,000,000 | 57.72% | 22.15% | 18.32% |
The table above — compiled from company filings — shows modest, consistent revenue growth across the period and resilient margin profiles. Gross margin expanded to 59.79% in 2024 from 57.78% in 2023, evidence of sustained pricing power and/or favorable mix in Water Quality.
Balance sheet and cash-flow trends: deleveraging and cash accumulation#
Veralto’s balance sheet shows two important directional moves in FY2024: higher cash balances and a material build in intangible assets (goodwill/intangibles at $3.23B), reflecting prior M&A, while long-term debt remained sizable at $2.73B. The combination of rising cash and falling net debt supports management’s ability to fund both inorganic growth and a richer shareholder-return program.
| Year | Cash & Equivalents | Total Assets | Total Debt | Net Debt | Total Equity | Free Cash Flow |
|---|---|---|---|---|---|---|
| 2024 | $1,100,000,000 | $6,410,000,000 | $2,770,000,000 | $1,670,000,000 | $2,040,000,000 | $820,000,000 |
| 2023 | $762,000,000 | $5,690,000,000 | $2,780,000,000 | $2,020,000,000 | $1,380,000,000 | $909,000,000 |
| 2022 | $0 | $4,830,000,000 | $123,000,000 | $123,000,000 | $3,230,000,000 | $836,000,000 |
| 2021 | $0 | $4,840,000,000 | $135,000,000 | $135,000,000 | $3,200,000,000 | $842,000,000 |
A few calculated metrics worth highlighting: the FY2024 free cash flow to net income conversion of +98.46%, a 12-month decline in reported free cash flow from 2023 to 2024 of -9.79% (820 / 909 - 1 = -0.0979), and a measured decline in net leverage (net debt / FY2024 EBITDA = 1.67 / 1.28 = 1.30x). These numbers align with a capital allocation tilt toward balance-sheet repair and conservative liquidity policy.
Earnings quality and guidance credibility#
Quality of earnings appears high: operating cash flow in FY2024 was $875 million, slightly ahead of net income, and depreciation & amortization was a modest $78 million, indicating the cash-to-earnings relationship is not being driven by large non-cash adjustments. Management’s Q2 2025 commentary and the company’s subsequent guidance raise were supported by a Q2 operating beat (Q2 revenue $1.371B, adjusted EPS $0.93) and improved free cash flow in the quarter ($323 million), which the company cited as the rationale for a higher full-year adjusted EPS range and a boost to dividend policy Veralto Q2 2025 Earnings Release.
Analytically, the guidance raise’s credibility is reinforced by the high free cash flow conversion metric and a net-debt decline, which together indicate management is not relying on financial engineering to hit targets. Yet not all trends are uniformly positive: Product Quality & Innovation (PQI) experienced near-term margin compression tied to integration costs and tariffs related to recent acquisitions. Those pressures explain why management emphasizes software/consumables growth as the path back to higher sustainable margins.
Strategic moves: TraceGains acquisition and water-technology optionality#
Veralto’s acquisition of TraceGains for $350 million (closed October 2024) is the single most important strategic transaction in the recent period because it plugs a high-recurring-revenue, high-margin software asset into PQI. The deal was structured to accelerate recurring revenue and expand cross-sell opportunities in food & beverage and other regulated industries. Management reports that TraceGains contributes to strong software/consumables growth within PQI (greater than +20% YoY in Q2) and will be a multi-year driver of incremental gross margin expansion once integration costs normalize Veralto TraceGains Acquisition Press Release and Reuters coverage.
Complementing the buy is a €20 million commitment to Emerald Technology Ventures’ Global Water Fund II, an early-stage water-tech fund that gives Veralto preferential access to sensors, membranes, and decentralized treatment technology. This commitment is strategic optionality rather than a large-scale capital allocation; it prioritizes access to technology and pilot partnerships over immediate financial returns and reflects a two-pronged approach: buy revenue today, buy optionality for tomorrow Emerald Technology Ventures: Global Water Fund II.
Competitive and margin implications: PQI transition and WQ strength#
The company’s competitive positioning sits at the intersection of industrial water solutions and product-quality services. Water Quality (WQ) demonstrated margin expansion — management cited WQ operating margins expanding and it contributed materially to the full-year EPS raise. PQI is undergoing a structural transition: adding TraceGains increases recurring revenue and gross-margin potential but brings near-term integration costs that compressed PQI margins in the most recent quarter (PQI operating margin slipped from 27.6% to 25.6% in the reported period — a -200 bps move). That margin compression is an expected short-term trade-off for higher long-term margin potential once the software mix scales.
From a competitive standpoint, the purchase of TraceGains creates a differentiated proposition: bundled software, services and consumables that can lock customers into recurring spend and create stickier revenue streams. This is important because industry peers that remain product- or hardware-centric will struggle to match the lifetime value profile of a software-plus-consumables business.
Valuation and forward estimates: checked against reported earnings#
Using market data in the provided dataset, the stock price quoted at $107.87 yields a FY2024 P/E of 30.13x (107.87 / 3.58). Calculating enterprise value with market cap $26.77B plus net debt $1.67B gives an implied EV of roughly $28.44B and an EV/EBITDA of ~22.23x using FY2024 EBITDA of $1.28B (28.44 / 1.28). Price-to-sales using FY2024 results is ~5.16x (26.77 / 5.19). Those valuation multiples are materially influenced by the company’s strong ROE and high margins, but they also reflect the market’s expectation for continued mid-single-digit growth and margin expansion as software and consumables scale.
Analyst-supplied estimates embedded in the dataset point to revenue rising toward $5.50B in 2025 and to $6.66B by 2029, implying a revenue CAGR over 2024–2029 in the ~5.12% range (calculated as (6.6577 / 5.19)^(1/5) - 1). Projected EPS moves from roughly the current $3.58–3.60 level toward $5.11 by 2029, which implies an EPS CAGR near +7.39% over five years by our calculation. Those growth rates fit the profile required to justify the current multiple if management executes the PQI transition and expands software margins as planned.
Risks and friction points#
Three risks stand out with measurable financial implications: integration and tariff costs that compress PQI margins in the near term; regional demand variability (notably weakness in China) that can undercut mid-single-digit topline targets; and the potential for capital deployment that dilutes returns if M&A prices are elevated. The PQI margin decline in the quarter (approximately -200 bps) and the 2024 decline in free cash flow versus 2023 (-9.79%) are the tangible, near-term evidence of these frictions. Investors should watch the cadence of PQI margin recovery and the pace of software/consumables cross-sell as primary indicators of whether TraceGains is delivering its expected financial uplift.
Key takeaways#
Veralto’s FY2024 and Q2 2025 results present a mixed but actionable picture. On the positive side, strong free cash flow (FCF) and near-100% FCF-to-income conversion, a reduction in net debt of -17.33%, and a strategic acquisition that accelerates software recurring revenue provide a durable foundation for the company’s stated objectives. On the cautionary side, PQI margin compression from integration and tariff headwinds, and regionally uneven demand, introduce execution risk that will determine whether the current multiples are earned.
What this means for investors#
Veralto has converted operating strength into optionality: it can prioritize debt paydown, targeted M&A, and a modestly richer dividend (quarterly payout increased from $0.09 to $0.11, a +22.22% step). The company’s high free cash flow conversion means these choices are supported by operating economics rather than financing. The TraceGains acquisition materially changes the revenue mix in PQI toward higher-margin recurring dollars — a long-term value driver — but it also raises near-term integration execution as the key watch item. For market participants evaluating execution risk versus cash-flow resilience, the next milestones to monitor are PQI margin stabilization, software substitution rates (migration of legacy customers), and quarterly free cash flow cadence relative to guidance.
Conclusion#
Veralto enters the back half of the year with a clearer strategic shape: the business is generating cash at near parity with reported earnings, net leverage is trending down, and management is actively redeploying capital into recurring-software revenue and selective innovation bets in water technology. Those moves create a credible path to higher margins and more predictable cash flows over time. The counterweight is the short-term friction from PQI integration and regional demand variability. The immediate analytic task for stakeholders is to watch execution — not intent — through PQI margin trends, recurring-revenue growth rates, and quarterly cash-flow conversion. If the company can sustain the high cash-conversion profile while driving software penetration materially higher, the structural narrative supporting current multiples becomes substantially stronger.
(Selected financial figures and segment commentary drawn from Veralto filings and the company’s Q2 2025 earnings materials; transaction details from Veralto press releases and Reuters coverage.)